report that NK‐1R antagonist treatment can induce gastrointestinal cancer cells apoptosis and inhibit tumor proliferation.36 Moreover, NK‐1R antagonists hypothetically alleviate the ailments which go along with cancer conventional therapy. The gene discussed is TACR1; the disease is neoplasm.